Myezom 2mg Injection

Product Description

Myezom 2mg Injection contains Bortezomib, which is a proteasome inhibitor used in the treatment of certain types of cancers, most commonly multiple myeloma and mantle cell lymphoma. Bortezomib acts by preventing the breakdown of proteins by cell structures called proteasomes, which causes a buildup of proteins in cancer cells and ultimately results in their death.

Before using Bortrac 2 Injection, speak with your doctor if you have problems with your heart, liver, kidneys, or bleeding. It is not advised to use effective contraception when pregnant or nursing, but it is necessary throughout therapy.

Brand Name: Myezom

Composition: Bortezomib

Mechanism of Action:

Proteases are important in the breakdown of proteins that control cell development, and boratezomib suppresses their action. Protease inhibition causes damaged proteins to accumulate in the cell, which kills cancer cells and slows the growth of tumors.

Uses:

• Multiple Myeloma
• Mantle Cell Lymphoma
• Waldenstrm's Macroglobulinemia
• Amyloidosis

Side Effects:

• Fatigue, weakness
• Nausea
• Fever
• Anemia
• Neutropenia
• Thrombocytopenia
• Numbness
• Rash
• Tumor Lysis Syndrome
• Herpes Zoster Reactivation

Dosage and Administration:

The dosage of Myezom is typically based on body surface area and is administered as an injection either subcutaneously (under the skin) or intravenously (into a vein).